Clinical Trials
44 trialsNCT01588522 2025-05-28
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia
BPGbio
Phase 1 Completed
NCT05252884 2025-02-07
Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial
Centro de Excelencia en Enfermedades de Cabeza y Cuello
Phase NA Completed
NCT03469271 2023-09-26
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Mayo Clinic
Phase 4 Completed
NCT01293682 2022-04-20
Effects of High Dose Calcitriol in Breast Cancer Patients
University of Rochester
Phase 2 Completed
NCT00482157 2022-03-03
Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
Stanford University
Phase NA Withdrawn
NCT01868750 2021-10-12
Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia
University of Virginia
Phase 2 Completed
NCT03261336 2021-02-08
Oral Calcitriol With Ketoconazole in CRPC
Inova Health Care Services
Phase 2 Terminated
NCT04637360 2020-11-19
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Min-Sheng General Hospital
Phase NA Completed
NCT00486512 2020-09-03
Chemoprevention of Colorectal Adenomas
Colotech A/S
Phase 3 Terminated
NCT01317940 2020-07-08
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Children's Hospital Los Angeles
Phase 2 Completed
NCT00301067 2019-06-04
Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
Northwestern University
Phase 1/2 Completed
NCT00904033 2019-04-23
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
University of Rochester
Phase 2 Completed
NCT00690924 2018-06-04
Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT00794547 2017-12-12
Phase I/II Calcitriol in Lung Cancer
University of Michigan Rogel Cancer Center
Phase 1/2 Terminated
NCT00524589 2017-11-20
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00536991 2017-06-14
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Roswell Park Cancer Institute
Phase 1/2 Terminated
NCT00084864 2017-06-12
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
Roswell Park Cancer Institute
Phase 2 Terminated
NCT03140449 2017-05-04
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
National Taiwan University Hospital
Phase 3 Completed
NCT00182741 2017-05-03
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00004043 2017-04-28
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00017576 2017-04-28
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00953849 2017-03-07
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
VA Office of Research and Development
Phase 1/2 Completed
NCT01093092 2016-01-12
Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1 Terminated
NCT00118066 2015-05-27
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00238199 2015-04-24
Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00010231 2015-03-30
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
University of Pittsburgh
Phase 1 Completed
NCT01358045 2015-01-13
Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma
Maastricht University Medical Center
Phase 2 Completed
NCT00084708 2014-01-13
Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Completed
NCT00008086 2013-12-19
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Completed
NCT00009802 2013-12-19
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
University of Pittsburgh
Phase 1 Completed
NCT00004928 2013-06-19
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00427804 2013-02-04
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Atlanta VA Medical Center
Phase NA Completed
NCT00238225 2013-01-31
Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors
Roswell Park Cancer Institute
Phase 1 Completed
NCT00383487 2013-01-28
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Stanford University
Phase 2 Terminated
NCT00926315 2012-11-01
Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation
University of Sao Paulo General Hospital
Phase NA Unknown
NCT00298545 2011-11-18
Effect of Vitamin D and Calcium on Genes in the Colon
Rockefeller University
Phase 1 Completed
NCT00054522 2011-03-08
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
Roswell Park Cancer Institute
Phase 2 Completed
NCT01039181 2009-12-24
Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
National Science and Technology Development Agency, Thailand
Phase 2 Unknown
NCT00055263 2009-07-28
A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies
Novacea
Phase 1 Completed
NCT00043576 2009-03-12
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Novacea
Phase 2/3 Unknown
NCT00273338 2007-11-06
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
Novacea
Phase 3 Terminated
NCT00536770 2007-11-06
A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Novacea
Phase 2 Suspended
NCT00066885 2007-05-07
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer
Novacea
Phase 1/2 Completed
NCT00285675 2006-05-31
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Novacea
Phase 2 Unknown